{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-010917","form_type":"8-K","ticker":"SLE","cik":"0001621672","company_name":"Super League Enterprise, Inc.","filed_at":"2025-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.083241+00:00","generated_at":"2026-05-23T22:37:47.513634+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Super League appoints new CEO, reports disappointing Q4/FY2024 results","bullets":["Aims to achieve EBITDA positive by Q4 2025; realigning cost structure and focusing on higher-margin programs.","Ann Hand becomes Executive Chair; Matt Edelman promoted to CEO, effective April 1, 2025.","Director Clark Callendar resigns; Bant Breen, founder of Qnary, appointed as independent director.","Exclusivity period with Infinite Reality expired; pursuing strategic alternatives with companies near breakeven.","New CEO Edelman receives $385k salary and 1M share option; Hand $425k salary and 700k option; Haynes $325k and 350k option."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-010917","json":"https://secwatch.observer/filing/0001437749-25-010917.json","markdown":"https://secwatch.observer/filing/0001437749-25-010917.md","text":"https://secwatch.observer/filing/0001437749-25-010917.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/slgg20250403_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T22:37:47.513634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2495a1b6e7","claim":"Matthew Edelman was appointed as Chief Executive Officer at Super League Enterprise, Inc..","evidence_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","confidence":0.95},{"claim_id":"5d51392dd3","claim":"Bant Breen was appointed as Class I member of the Board of Directors at Super League Enterprise, Inc..","evidence_excerpt":"Effective April 1, 2025, the Company appointed Bant Breen as a Class I member of the Board of Directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","confidence":0.95},{"claim_id":"654b0d7cd2","claim":"Clark Callandar resigned as Class I member of the Board of Directors at Super League Enterprise, Inc..","evidence_excerpt":"Effective March 31, 2025, Clark Callandar resigned as a Class I member of the Board of Directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","confidence":0.95},{"claim_id":"d692019aa5","claim":"Ann Hand was appointed as Executive Chair at Super League Enterprise, Inc..","evidence_excerpt":"Ann Hand, who was appointed Executive Chair effective April 1, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm"}},{"accession":"0001193125-26-249692","ticker":"ELOX","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2026-06-01T11:00:19+00:00","headline":"Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors","event_type":"other_material","sec_items":["3.02","3.03","5.03","5.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249692","json":"https://secwatch.observer/filing/0001193125-26-249692.json","markdown":"https://secwatch.observer/filing/0001193125-26-249692.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/d261568d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm"}},{"accession":"0001104659-26-068521","ticker":"FDXF","company_name":"FedEx Freight Holding Company, Inc.","filed_at":"2026-06-01T10:46:03+00:00","headline":"FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed","event_type":"other_material","sec_items":["1.01","2.03","3.03","5.03","5.01","5.02","5.05","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068521","json":"https://secwatch.observer/filing/0001104659-26-068521.json","markdown":"https://secwatch.observer/filing/0001104659-26-068521.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/tm2615735d2_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm"}},{"accession":"0001829126-26-005831","ticker":"FXAC","company_name":"FortuneX Acquisition Corp","filed_at":"2026-05-29T21:32:49+00:00","headline":"FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-005831","json":"https://secwatch.observer/filing/0001829126-26-005831.json","markdown":"https://secwatch.observer/filing/0001829126-26-005831.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/fortunexacq_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm"}},{"accession":"0001171843-26-003809","ticker":"CRMT","company_name":"AMERICAS CARMART INC","filed_at":"2026-05-29T21:30:17+00:00","headline":"America's Car-Mart forms special committee for strategic alternatives; appoints new independent director","event_type":"other_material","sec_items":["1.01","5.02","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003809","json":"https://secwatch.observer/filing/0001171843-26-003809.json","markdown":"https://secwatch.observer/filing/0001171843-26-003809.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/f8k_052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm"}},{"accession":"0000947871-26-000585","ticker":"MVST","company_name":"Microvast Holdings, Inc.","filed_at":"2026-05-28T21:26:49+00:00","headline":"Microvast CEO converts $25M loan to equity; CAO Eric Garcia departs","event_type":"other_material","sec_items":["5.02","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-26-000585","json":"https://secwatch.observer/filing/0000947871-26-000585.json","markdown":"https://secwatch.observer/filing/0000947871-26-000585.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760689/000094787126000585/0000947871-26-000585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760689/000094787126000585/ss6384648_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"On May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer of Microvast Holdings, Inc. (the “Company”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1760689/000094787126000585/0000947871-26-000585-index.htm"}},{"accession":"0001493152-26-026544","ticker":"LIXT","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2026-06-01T12:55:34+00:00","headline":"Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board","event_type":"other_material","sec_items":["5.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026544","json":"https://secwatch.observer/filing/0001493152-26-026544.json","markdown":"https://secwatch.observer/filing/0001493152-26-026544.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/form8-k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm"}},{"accession":"0001628280-26-038821","ticker":"ENS","company_name":"EnerSys","filed_at":"2026-05-28T20:15:50+00:00","headline":"EnerSys realigns to three segments, names presidents for NIS, IMS, PPS","event_type":"other_material","sec_items":["5.02","7.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-038821","json":"https://secwatch.observer/filing/0001628280-26-038821.json","markdown":"https://secwatch.observer/filing/0001628280-26-038821.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289308/000162828026038821/0001628280-26-038821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289308/000162828026038821/ens-20260528.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm","comparable_excerpt":"As a result of the Company's Segment Realignment there will be a change in executive titles as follows: • Keith D. Fisher – President, Network & Infrastructure Solutions • Chad C. Uplinger – President, Industrial Mobility Solutions • Mark E. Matthews – Chief Technology Officer and President, Precision Power Solutions","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289308/000162828026038821/0001628280-26-038821-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}